Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRAPARIB vs NIROGACESTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRAPARIB vs NIROGACESTAT: Safety Overview

Metric NIRAPARIB NIROGACESTAT
Total FAERS Reports 21,634 497
Deaths Reported 1,370 7
Death Rate 6.3% 1.4%
Hospitalizations 4,892 54
Average Patient Age 65.7 yrs 45.2 yrs
% Female Patients 98.5% 69.6%
FDA Approval Date Apr 26, 2023 N/A
Manufacturer GlaxoSmithKline LLC SpringWorks Therapeutics, Inc.
Route ORAL ORAL
Marketing Status Discontinued N/A